Ambry Genetics is a genomic services provider specializing in next-gen sequencing, microarrays, genotyping and bioinformatics. Ambry scientists have been working with NGS platforms since 2007 and is both College of American Pathologists (CAP)-accredited and Clinical Laboratory Improvement Amendments (CLIA)-certified. As a leader in clinical genetic diagnostics and genetics software solutions, Ambry Genetics combines both to offer the most comprehensive testing solutions in the industry.